Shares of U.K.-based drugmaker AstraZeneca were climbing 5.5% Wednesday morning on an anonymously sourced report from a prominent British journalist claiming the medical journal the Lancet will publish “positive news soon” on the Covid-19 vaccine the company is developing with Oxford University.
AstraZeneca (ticker: AZN) declined to comment on the report through an external spokesman.
The brief article, which appeared early Wednesday on the website of the British television network ITV, was by Robert Peston, ITV News’ political editor. Peston writes that the Lancet will publish positive news on the Oxford vaccine, and that the paper will show that the vaccine elicited both antibody and T-cell responses in study participants.
The article has few details, and the source isn’t identified or described. Still, investors appear to be taking the bait. AstraZeneca’s American depositary receipts, which closed Tuesday at $53.98, were trading at $56.92 by midmorning Wednesday.
The best of the Muslim Times’ collection for war against Covid 19:
In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.
For the latest news about drugs and vaccines’ trials please go to: Pharmaceutical-Technology
For the latest health news from BBC, Please click here
The Muslim Times has the best collections in the war against Covid 19 as we are collecting from all the established sources
For the number of cases and epidemiology in each country go to: WorldOMeters
DAILY NEW CASES AND DEATHS IN US, CDC SITE